Clinical Trial Technology Editorial
-
Harness MDIC's Collaborative Resources to Strengthen Clinical Trials and Patient Outcomes
2/13/2025
Discover how resources from the Medical Device Innovation Consortium (MDIC) can help advance clinical trials for better patient outcomes.
-
The Scoop On SCOPE
2/7/2025
Chief Editor Dan Schell summarizes some of his favorite quotes and learnings from the 2025 SCOPE Summit. Spoiler alert … Not everything is about AI these days.
-
A Tool To Tackle The Risk Of Uninformative Trials
1/31/2025
Uninformative trials hinder progress in clinical practice, policy decisions, and further research. Fast Data Science developed a free risk tool to help pharma companies avoid them.
-
In Clinical Research, Every Day Is Groundhog Day
1/30/2025
Rather than proffer some New Year's predictions, Paul Ivsin looks at clinical research through the lens of Groundhog Day and the tradition of reinventing the same thing over and over again.
-
Tech Vendors Are Today's Don Quixotes
1/28/2025
Don Quixote is known for tilting at windmills, believing them to be enemies. Today, it seems, emerging tech solution developers are embodying the spirit of the quixotic knight centuries later.
-
Strategizing And Implementing Your Clinical Trial Technologies
1/23/2025
An implementation strategy will help you overcome challenges in integrating tech such as electronic clinical outcome assessments, electronic patient reported outcomes, and digital health technologies.
-
We're Looking At Patient Recruitment All Wrong
1/22/2025
Leanne Woehlke, a 30-year veteran of the clinical research industry, says our standard patient recruitment efforts are lacking one key element — a focus on the patient’s needs.
-
Takeda Taps AI Partner To Improve Patient Selection, Clinical Assessments, And Treatment Pathways For IBD
1/10/2025
Takeda's Vijay Yajnik, MD, Ph.D. describes the company's partnership with an AI/ML vendor to improve endoscopic assessments in inflammatory bowel disease (IBD) research.
-
How AI Will Transform Health Equity In Clinical Trials In 2025
12/23/2024
Click Therapeutics' CMO/CSO Shaheen Lakhan, MD, Ph.D., FAAN explains how the shift toward AI is the first step in addressing diversity in clinical trials.
-
AI Won't Save Us: Why We Must Save Ourselves
12/20/2024
We need to bring automation, technology, and AI to the true bottlenecks of drug development — not just the early discovery phases or broader topics such as site selection but the nuts and bolts of clinical trial execution. AI can help reduce the day-to-day burden on clinical trial sites, automate repetitive tasks, and minimize the manual work that adds no value but leads to burnout.